In a retrospective study with 13,939 breast cancer patients, patients with the Luminal A subtype had the lowest pCR rate (0.3%) and the highest pCR rate was observed in HER-2 positive patients (38.7%) 27. Here, ERBB2 is linked to breast carcinoma.